EODData

FRA, 1OT: Ovid Therapeutics Inc

18 Aug 2026
LAST:

2.440

CHANGE:
 0.04
OPEN:
2.440
HIGH:
2.440
ASK:
0.000
VOLUME:
0
CHG(%):
1.67
PREV:
2.400
LOW:
2.440
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
18 Aug 262.4402.4402.4402.4400
17 Aug 262.3802.4002.3802.4000
14 Aug 262.3602.3602.3602.3600
13 Aug 262.2402.2402.2402.2400
12 Aug 262.2002.2002.2002.2000
07 Aug 262.2402.2402.2402.2400
06 Aug 262.2802.2802.2802.2800
05 Aug 262.1002.1002.1002.1000
04 Aug 261.9901.9901.9901.9900
03 Aug 261.8901.8901.8901.8900

PROFILE

Name:Ovid Therapeutics Inc
About:Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and pediatric drug-resistant epilepsies; and OV350, a small molecule direct activator of the KCC2 transporter, which is in Phase 1 clinical trials for treating epilepsies. It develops OV350 IV, OV4071, and OV4041, an oral program that behave similarly in phenotypical screens for the treatment of psychosis in people with NSD and LBD; and OV888 (GV101), a highly selective rock2 inhibitor which is in Phase 1 double-blind multiple-ascending dose trial. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
Sector:Healthcare
Industry:Biotechnology
Address:441 Ninth Avenue, New York, NY, United States, 10001
Website:https://www.ovidrx.com
ISIN:US6904691010
LEI:549300H36NUI4L6U8F17

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-9.65 
Forward P/E:-2.84 
PEG Ratio:0.68 
Price to Sales:61.85 
Price to Book:2.27 
Operating Margin:-6.79 
Return on Assets:-0.20 
Return on Equity:-0.19 
Revenue:6.24M 
Shares:71.11M 
Market Cap:173.51M 

TECHNICAL INDICATORS

MA5:2.334.8%
MA10:2.2110.2%
MA20:2.1215.1%
MA50:2.1115.7%
MA100:2.1613.1%
MA200:1.7440.4%
STO9:100.00 
STO14:100.00 
RSI14:72.00 
MTM14:0.42
ROC14:0.21 
ATR:0.07 
Week High:2.440.0%
Week Low:2.2010.9%
Month High:2.440.0%
Month Low:1.8940.4%
Year High:2.523.3%
Year Low:0.76221.1%
Volatility:7.54